What Does International Association for the Study of Lung Cancer Do?

Total employees93
HeadquartersCentennial
Founded1974

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, IASLC's membership base includes more than 10,000 lung and thoracic cancer specialists across all disciplines in over 100 countries. The association's core purpose is to conquer lung and other thoracic cancers on a worldwide basis by promoting research, education, and collaboration among scientists, clinicians, and patients. IASLC publishes the Journal of Thoracic Oncology (JTO) and organizes the renowned World Conference on Lung Cancer (WCLC) among other educational events.

Where Is International Association for the Study of Lung Cancer's Headquarters?

HQ Function

The headquarters serves as the central administrative and operational hub for IASLC's global activities, including membership services, organization of major conferences like the WCLC, development of educational programs, management of publications, and coordination of advocacy and research initiatives.

Notable Features:

The headquarters likely comprises modern office facilities designed to support a global non-profit's administrative and collaborative needs, including meeting spaces and technological infrastructure for international communication.

Work Culture:

As a mission-driven non-profit, the work culture at IASLC headquarters is characterized by professionalism, collaboration, and a strong dedication to the fight against lung cancer. Staff are typically passionate about contributing to global health outcomes and advancing oncological science.

HQ Significance:

IASLC's headquarters is pivotal as the coordinating center for an extensive international network of researchers, clinicians, patient advocates, and industry partners focused on thoracic oncology. It facilitates global collaboration, knowledge dissemination, and the strategic direction of the association's worldwide efforts.

Values Reflected in HQ: The headquarters' operations aim to reflect IASLC's core values: commitment to research and education, global collaboration, scientific integrity, and a patient-centric approach to conquering thoracic cancers.

Location:

IASLC maintains a significant global presence through its diverse membership spanning over 100 countries. Its worldwide functions are primarily supported through international conferences (such as the World Conference on Lung Cancer held in various global locations), regional meetings, educational workshops, online resources, publications like the Journal of Thoracic Oncology, and collaborative research initiatives. While the administrative headquarters is in Colorado, USA, IASLC's activities, educational outreach, and member engagement are inherently global, fostering a worldwide community dedicated to tackling thoracic cancers.

Street Address:

9000 E. Nichols Ave, Suite 215

City:

Centennial

State/Province:

Colorado

Country:

USA

Where Else Does International Association for the Study of Lung Cancer Operate Around the World?

No additional office locations available.

Buying Intent Signals for International Association for the Study of Lung Cancer

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading International Association for the Study of Lung Cancer? Meet the Executive Team

As of April 2025, International Association for the Study of Lung Cancer' leadership includes:

Destiny M. H. Coleman, M.Ed., CMP, CAE - Chief Executive Officer
Heather A. Wakelee, MD, FASCO - President (2023-2025)
Paul Van Schil, MD, PhD - President-Elect
Charles M. Rudin, MD, PhD - Past President
Murry W. Wynes, PhD - Chief Scientific Officer

Who's Investing in International Association for the Study of Lung Cancer?

International Association for the Study of Lung Cancer has been backed by several prominent investors over the years, including:

AstraZeneca
Roche/Genentech
Merck (MSD)
Bristol Myers Squibb
Takeda Oncology
Johnson & Johnson Innovative Medicine
Novartis
Eli Lilly and Company
Amgen
Boehringer Ingelheim

What Leadership Changes Has International Association for the Study of Lung Cancer Seen Recently?

Hire1
Exits1

IASLC experienced a key leadership change in the last 12 months with the appointment of Destiny M. H. Coleman as the new Chief Executive Officer in May 2024, succeeding Dave Mesko. This transition is pivotal for the ongoing strategic leadership and operational excellence of the association.

Departures

Dave Mesko, JD, Dave Mesko stepped down from his role as Chief Executive Officer of IASLC.

New Appointments:

Destiny M. H. Coleman, M.Ed., CMP, CAE, Destiny M. H. Coleman was appointed as the new Chief Executive Officer of IASLC, bringing extensive experience in association management.

What Technology (Tech Stack) Is Used byInternational Association for the Study of Lung Cancer?

Discover the tools International Association for the Study of Lung Cancer uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

International Association for the Study of Lung Cancer Email Formats and Examples

The International Association for the Study of Lung Cancer (IASLC) commonly uses an email format consisting of the first initial followed by the last name for its staff members (e.g., jsmith@iaslc.org). General inquiries can often be directed to departmental email addresses like info@iaslc.org or membership@iaslc.org.

[first_initial][last]@iaslc.org

Format

dcoleman@iaslc.org

Example

80%

Success rate

What's the Latest News About International Association for the Study of Lung Cancer?

IASLC Website / PR NewswireMay 1, 2024

IASLC Names Destiny M. H. Coleman, M.Ed., CMP, CAE, New Chief Executive Officer

The International Association for the Study of Lung Cancer (IASLC) announced the appointment of Destiny M. H. Coleman as its new Chief Executive Officer. Coleman assumed the role on May 1, 2024, succeeding Dave Mesko, JD....more

IASLC WebsiteMarch 12, 2024

IASLC Announces Keynote Speakers for 2024 World Conference on Lung Cancer

IASLC revealed the lineup of distinguished keynote speakers for its upcoming 2024 World Conference on Lung Cancer (WCLC 2024), set to take place in San Diego, California. The speakers will address pivotal topics in lung cancer research, treatment, and patient advocacy....more

Business WireJanuary 10, 2024

IASLC Announces 2024 Targeted Therapies of Lung Cancer Meeting Program

The IASLC unveiled the comprehensive program for its 2024 Targeted Therapies of Lung Cancer Meeting (TTLC24), held in February in Santa Monica, California. The program featured leading experts discussing the latest advancements and future directions in precision medicine for lung cancer....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including International Association for the Study of Lung Cancer, are just a search away.